🇺🇸

Broad Market

· monthly

US Pre-Market SEC Filings Roundup — July 17, 2026

Overnight SEC filings reveal a market bifurcated between aggressive capital deployment and fundamental deterioration. The most dominant theme is a wave of transformative M&A and capital markets activity, including NextEra Energy's $2.25 billion deal to acquire Dominion Energy, IPG Photonics' €300 million acquisition of Lumibird Medical, and Jasper Therapeutics' dilutive $132 million PIPE-funded merger with Kira Pharmaceuticals. However, this optimism is counterbalanced by severe operational stress in several sectors. Frequency Electronics reported a dramatic swing from a $23.7M profit to a $0.9M loss, while AITX's cash position dwindled to just $95K against $44.9M in current liabilities. Insider activity is sending mixed signals: a massive $319M purchase by Sumitomo Mitsui in Jefferies Financial Group signals strong institutional conviction, while a $1.8M sale by Marvell's Data Center President raises questions about peak valuation. The financial sector shows a clear divergence, with Truist and Fifth Third posting strong YoY earnings growth driven by fee income and M&A integration, while Regions Financial reported flat revenue and elevated net charge-offs. The SPAC market remains active but challenged, with Papaya Growth's cash trust depleting and Sigyn Therapeutics deregistering entirely, highlighting the ongoing shakeout in blank-check companies.

29 high priority 21 medium 50 total filings
· daily

US Material Events SEC 8-K Filings — July 16, 2026

The July 16, 2026 filings reveal a market dominated by transformative M&A and distressed restructuring, with significant capital flowing into neuroscience, solar infrastructure, and defense technology. Key period-over-period trends are limited as most filings lack comparative financials, but notable exceptions include a high-margin acquisition (8.8x EBITDA) and a distressed debt-for-equity swap. The most critical developments are Eli Lilly's $3.8B acquisition of atai Life Sciences for its depression pipeline, Uber's $14.8B bid for Delivery Hero, and the bankruptcies of Inotiv and SpringBig, which signal a bifurcated market where well-capitalized firms aggressively consolidate while over-leveraged names face extinction. Insider activity is sparse but includes a CEO's performance-based RSU grant tied to a $100B value creation target. Portfolio-level patterns show a clear tilt toward neuroscience, solar infrastructure, and rare earth supply chains, with capital allocation favoring debt restructuring and strategic acquisitions over dividends.

50 high priority 50 total filings
· daily

Global High-Priority Regulatory Events — July 16, 2026

The 42 filings from July 16, 2026, reveal a market sharply bifurcated between aggressive corporate restructuring and acute financial distress. A dominant theme is the wave of M&A and capital realignment, particularly in India, where companies like Aurum PropTech, HCLTech, and RSC International are executing high-value acquisitions and share swaps to consolidate market positions. Concurrently, a significant number of entities are facing existential threats: Inotiv, Winsome Yarns, and SpringBig Holdings are undergoing Chapter 11 or insolvency processes that will wipe out existing equity holders, while Mangalam Drugs and Cycurion face imminent default and delisting risks. The data shows a clear pattern of 'haves' using strong balance sheets to acquire growth, and 'have-nots' succumbing to debt and regulatory pressures. Insider activity is sparse but telling, with the Kobo Biotech insolvency failure and the Chart Industries/Baker Hughes merger completion representing the most material events. The forward-looking calendar is packed with shareholder meetings and regulatory deadlines, particularly in August 2026, which will be a critical month for many of these corporate actions.

42 high priority 42 total filings
· daily

US SEC Filings Daily Market Digest — July 16, 2026

Today's digest is dominated by transformative corporate actions: a major $14.8B cross-border bid from Uber for Delivery Hero, a prepackaged Chapter 11 wipeout for Inotiv, and a significant debt-for-equity swap at ASP Isotopes. The quarter's market sentiment from corporate results (GE Aerospace, UnitedHealth) is a clear 'mixed' picture: top-line expansion is accompanied by margin compression, elevated investment spending, and shrinking member rolls. The passive fund flows and insider activity paint a cautious picture, with two senior Sea Ltd executives selling under 10b5-1 plans, and the CEO of Essent Group liquidating ~$5M in stock. Capital allocation remains bifurcated: KB Financial completes a $600M buyback for cancellation, Dorian LPG pays a special $1/sh dividend from a vessel sale, while Inotiv equity goes to zero. The clearest forward-looking signal is Uber’s massive strategic pivot into food delivery with a H2 2027 target close, which, combined with GE’s upgraded full-year outlook, provides the strongest bullish catalysts in the pipeline.

25 high priority 25 medium 50 total filings
· monthly

US Pre-Market SEC Filings Roundup — July 16, 2026

Overnight SEC filings from July 15-16, 2026, reveal a mixed landscape of strong earnings, insider profit-taking, and significant corporate restructurings. UnitedHealth Group reported Q2 adjusted EPS of $6.38 (up 23.4% YoY) and raised full-year guidance, but membership declined by 525,000 sequentially, signaling a structural headwind. Insider selling was notable, with Clear Secure's CEO and director entity selling ~$10M combined and Essent Group's Chairman selling $5.13M, suggesting management may see current valuations as attractive for exits. Inotiv's Chapter 11 confirmation wiped out equity holders entirely, while XOMA Royalty's Nasdaq delisting and Senti Biosciences' potential 77.5% dilution highlight severe risks in small-cap biotech. On the positive side, capital returns accelerated: KB Financial completed a KRW 600B buyback (1.01% of shares) and plans cancellation, and Dorian LPG declared a $1.00 special dividend. Awareness Group's revenue surged 1,045% YoY, though it remains in negative equity. The overnight filings also revealed governance issues at IRIDEX (stealth proxy campaign) and notable acquisition activity by NextPlat and Stereotaxis. Overall, investors should focus on the dichotomy between strong earnings at large caps and severe dilution/bankruptcy risks in smaller names.

30 high priority 20 medium 50 total filings
· daily

US Material Events SEC 8-K Filings — July 15, 2026

The 49 filings reveal a market dominated by significant capital markets activity and corporate restructuring, with a notable wave of debt refinancing totaling over $6 billion from Sunbelt Rentals, SBA Communications, Prestige Consumer Healthcare, and others. M&A activity is highlighted by TriCo Bancshares' acquisition by First Hawaiian in a tax-free stock-for-stock deal valued at 2.095x, and the restructuring of Senti Biosciences and Glucotrack via spin-offs and reverse mergers. Biotech companies are aggressively raising capital: Q32 Bio ($187.6M equity), AEON Biopharma ($13.75M+ warrants), and Fermi Inc. ($431.25M convertible) for advanced projects. However, governance risks are elevated, with High Wire Networks restating three quarters due to a $1.37M error, Regen BioPharma facing going concern and auditor changes, and Lipella Pharma filing for Chapter 11 bankruptcy. Leadership transitions are widespread, including CEO successions at Hanover Insurance and RxSight, and CFO retirements at Celldex. The overall theme is a bifurcated market: strong firms lock in low-cost debt while weaker firms restructure or face liquidity pressures.

49 high priority 49 total filings
· daily

Global High-Priority Regulatory Events — July 15, 2026

This digest covers 50 filings, predominantly from US and Indian markets, with a heavy concentration of negative events including 8 Nasdaq delistings (all effective July 23, 2026) and multiple insolvencies and defaults. Key themes include a wave of small-cap biotech and SPAC restructurings, significant M&A activity in Indian financial services and manufacturing, and heightened regulatory enforcement by SEBI. Period-over-period data reveals deteriorating financial health at several companies, such as Exide's subsidiary showing a 34% revenue decline and a widening loss, while others like POCL Enterprises are acquiring profitable assets. Insider activity is limited, but the lack of insider buying in distressed companies is notable. The most critical development is the mass delisting of 8 companies from Nasdaq, which will severely impact liquidity and shareholder value. Portfolio-level patterns indicate a bifurcation between cash-rich acquirers and cash-strapped companies facing insolvency or delisting.

50 high priority 50 total filings
· daily

US SEC Filings Daily Market Digest — July 15, 2026

Today's digest (July 15, 2026) is dominated by a wave of Nasdaq delistings, with six companies (Actelis Networks, American Rebel Holdings, Blue Hat Interactive, Captivision, Sleep Number, and X3 Holdings) all set for removal on July 23, 2026, signaling a significant purge of non-compliant micro-cap names. On the positive side, ASML delivered a standout quarter with Q2 net sales of €9.3B and raised its full-year 2026 outlook to €43-45B, while M&T Bank reported record diluted EPS of $5.32, up 29% QoQ and 25% YoY, though its CET1 ratio declined. The healthcare sector shows mixed signals: Elevance Health beat adjusted EPS expectations but saw GAAP EPS fall 13.1%, while Fractyl Health reported promising one-year data for its Revita procedure. Capital markets activity includes a $200M SPAC IPO from Jones Ventures INTL Acquisition1 Corp and a $13.75M offering from AEON Biopharma. Insider activity is notably absent across filings, but several 13F filings reveal institutional positioning, with a defensive tilt toward fixed-income ETFs and large-cap tech. Overall, the day presents a bifurcated picture: strong operational results from large caps versus existential risks for small caps, with several catalyst events (earnings calls, merger votes) on the near-term horizon.

13 high priority 37 medium 50 total filings
· monthly

US Pre-Market SEC Filings Roundup — July 15, 2026

Overnight SEC filings reveal a stark bifurcation between companies executing well and those facing existential threats. The most critical theme is a wave of Nasdaq delistings, with five companies (Actelis Networks, American Rebel Holdings, Blue Hat Interactive, Captivision, Sleep Number, and X3 Holdings) all set to be removed from the exchange on July 23, 2026, representing a significant liquidity and reputational blow for shareholders. On the positive side, ASML delivered a standout quarter with Q2 2026 net sales of €9.3 billion and raised its full-year 2026 outlook to between €43 billion and €45 billion, signaling robust demand in the semiconductor capital equipment space. Insider activity was mixed but notable: the CEO of BeOne Medicines sold over $22 million in stock through a 10b5-1 plan, while the CEO of Grab Holdings also sold $1.56 million, creating negative sentiment. Conversely, the CEO of Navios Maritime Partners made small open-market purchases totaling ~$252K, a modestly bullish signal. Capital allocation trends were highlighted by AEON Biopharma's $13.75 million public offering to fund its biosimilar pipeline, and SK hynix's massive $26.5 billion ADR offering, the largest capital raise in the batch. A significant governance event is the activist filing at Tax-Free Fixed Income Fund for Puerto Rico Residents, where a group holding 13.2% of shares is pushing a shareholder proposal. Overall, the data suggests a market rewarding strong operational performance (ASML) while punishing companies with weak fundamentals or compliance issues, with the delisting cluster being the most actionable risk signal.

40 high priority 10 medium 50 total filings
· daily

US Material Events SEC 8-K Filings — July 14, 2026

The July 14, 2026 filings reveal a market sharply bifurcated between aggressive capital deployment (M&A, buyouts, and debt offerings) and operational distress signals, particularly in the industrial and small-cap biotech sectors. The most significant themes are the privatization of two major real estate and events platforms (Whitestone REIT and Emerald Holding) by large asset managers, and a wave of dilutive financing and going-concern warnings among micro-cap companies. Period-over-period data highlights severe margin compression in the industrial sector, with Wabash National swinging to a negative adjusted EBITDA, while Kestra Medical shows strong top-line growth (66% YoY) but widening losses from heavy investment. Insider activity is muted, but several CEO/CFO changes and a costly financing structure at Edgemode signal underlying stress. Forward-looking guidance from Kestra (44% FY27 revenue growth) and the massive $1.1B biotech deal for Spero/Innovent provide positive catalysts, while the contingent FDA approval for Capricor's lease and the $320M PIPE for the NextCure/Avere merger create binary events. The digest highlights a 'haves and have-nots' dynamic, where well-capitalized entities are consolidating assets, while cash-strapped companies resort to punitive financing terms.

50 high priority 50 total filings
· daily

Global High-Priority Regulatory Events — July 14, 2026

This digest covers 46 filings from July 14, 2026, dominated by a wave of M&A completions and insolvency proceedings. A clear theme is the acceleration of take-private and strategic acquisitions, with four major deals closing on the same day: Apollo's $1.7B acquisition of Whitestone REIT, Apollo's acquisition of Emerald Holding, Ligand's $739M acquisition of XOMA Royalty, and Ares Management's acquisition of Whitestone REIT. On the distress side, multiple companies remain under CIRP, including Gensol Engineering, where a ₹673 crore fraud declaration adds significant risk. Period-over-period data reveals mixed performance: Hero MotoCorp's associate Ather Energy saw turnover more than double from ₹1,753.8 crore in FY24 to ₹3,671.76 crore in FY26, while DSM Fresh Foods' subsidiary Avyom Foodtech saw a 23.8% revenue decline. Insider activity is limited, but the significant gap between the open offer price of ₹56.84 and the market price of ₹232.50 for Lippi Systems highlights a potential value disconnect. Capital allocation trends show a preference for growth investments, with Hero MotoCorp committing up to ₹1,000 crore to Ather Energy and Linde India completing a ₹105 crore renewable energy investment. The most critical development is the successful closure of CIRP for Prime Focus Limited following a ₹353.8 crore settlement, signaling a positive resolution in a high-profile insolvency case.

46 high priority 46 total filings
· daily

US SEC Filings Daily Market Digest — July 14, 2026

Today's 50 filings paint a picture of a bifurcated market: large-cap banks (JPMorgan, Wells Fargo) delivered strong YoY revenue growth (27% and 9% respectively) but face net interest margin compression, while small-cap names like OFA Group and BlueOne Card show widening losses and cash burn. Semiconductor capacity expansion is a clear theme, led by Tower Semiconductor's $3B Japan investment and SemiLEDs' equipment-driven revenue spike. Insider selling at Sea Ltd (COO sold $1M, CCO sold $59K) contrasts with no insider buying elsewhere. Corporate governance changes at Gamehaus and Mint Inc concentrate voting power, and clinical-stage companies (Alto Neuroscience, IGC Pharma) continue to raise capital. The energy sector shows mixed signals with BP guiding lower upstream production and Equinor executing buybacks. The most critical developments include CleanSpark's 20-year data center lease, AstraZeneca's $600M upfront license deal, and Pacific Airport's traffic decline and guidance cut. Overall, investors should favor large-cap financials with pricing power, monitor semiconductor supply chain plays, and avoid cash-burning micro-caps without clear catalysts.

18 high priority 32 medium 50 total filings
· monthly

US Pre-Market SEC Filings Roundup — July 14, 2026

Overnight SEC filings from July 13-14, 2026 reveal a market bifurcated between strategic industrial expansion and consumer/tech headwinds. Tower Semiconductor's $3B Japan capacity expansion and CleanSpark's 175 MW data center lease signal major infrastructure plays, while SemiLEDs' revenue surge from buy-sell orders and OFA Group's 255% revenue growth mask underlying operational fragility. Insider selling at Sea Ltd ($1.02M by COO) and RH ($412K by director) contrasts with director accumulation at Gogoro (9.56M shares). Period-over-period trends show margin compression at Destiny Media (-170 bps gross margin) and Unity Bancorp (-12.2% YoY net income), while BP's guidance warns of lower production and a $1B charge. The most critical developments are Tower's 2028 revenue target of $3.6B, CleanSpark's AI infrastructure catalyst, and Coronado Global's CEO change amid profitability struggles.

25 high priority 25 medium 50 total filings
· daily

US Material Events SEC 8-K Filings — July 13, 2026

The July 13, 2026, filings reveal a market sharply bifurcated between aggressive capital deployment and acute financial distress. Major capital markets events dominate, with **Public Storage** raising $900M in senior notes to fund a transformative acquisition and **Talos Energy** issuing $800M in high-yield notes for a Gulf of America acquisition, while **Realty Income** expanded its credit facilities to $5.5B. The biotech sector saw a landmark transaction as **Edgewise Therapeutics** sold its muscular dystrophy business for up to $2.65B, and **Agenus** secured $340M for a pivotal Phase 3 trial. Conversely, several companies are in dire straits: **MSP Recovery** received a $250K emergency advance amid ongoing financial distress, **Splash Beverage** settled $2.8M in debt for a mere $302K, and **Silo Pharma** is raising $11.7M via a dilutive private placement. A wave of insider activity is notable, with multiple CFO and CRO departures, including **CoStar Group** appointing a new CFO who delivered a 25% cost reduction, and **Shutterstock** seeing its CEO step down immediately. The overall sentiment is mixed, with large-scale strategic moves and liquidity events contrasting with numerous small-cap distress signals and leadership transitions.

50 high priority 50 total filings
· daily

Global High-Priority Regulatory Events — July 13, 2026

This digest covers 50 filings, predominantly focused on severe distress signals across US and Indian markets. The most critical theme is a wave of Nasdaq delistings, with 8 companies facing final removal in late July 2026, including Esperion Therapeutics, CERO Therapeutics, and REE Automotive, reflecting a broad failure to meet listing standards. M&A activity is bifurcated: high-value strategic deals like Edgewise Therapeutics' $1.55B asset sale contrast with numerous small-scale acquisitions and SPAC maneuvers. A significant cluster of Indian companies (MTNL, Ansal Properties, Simbhaoli Sugars, Reliance Home Finance) are in advanced stages of insolvency or default, highlighting systemic stress in Indian real estate and telecom. Insider activity is notably absent across all filings, a bearish signal suggesting management lacks conviction. Forward-looking data reveals a packed catalyst calendar with several tender offers and SPAC deadlines expiring in late July and August 2026.

50 high priority 50 total filings
· daily

US SEC Filings Daily Market Digest — July 13, 2026

Today's digest is dominated by corporate actions and governance events, with a notable cluster of proxy fights and M&A-related votes. The most critical development is the impending delisting of Bowen Acquisition Corp (BOWN) from Nasdaq, a high-severity event that crystallizes the risks of SPAC investing. A significant proxy battle is underway at XAI Octagon Floating Rate & Alternative Income Trust (XFLT), where the board is seeking to replace the severely underperforming sub-adviser Octagon, who is fighting back. The merger of equals between Equitable Holdings and Corebridge Financial is driving a wave of proxy solicitations across multiple AB funds, creating a near-term catalyst calendar. On the financial health front, Patriot National Bancorp's removal of its 'troubled condition' designation marks a major turnaround, while Onar Holding Corp's deteriorating cash position and widening deficit present a stark contrast. Period-over-period trends from the limited operating data available show a mixed picture: Onar's revenue grew 39% YoY but gross profit collapsed 41%, while Royale Energy narrowed its net loss by 42% despite a 14% revenue decline. The 13F filings reveal a defensive posture among institutional managers, with heavy allocations to fixed-income, inflation-protected, and large-cap ETFs, signaling cautious market positioning.

11 high priority 39 medium 50 total filings
· monthly

US Pre-Market SEC Filings Roundup — July 13, 2026

Overnight SEC filings from July 12-13, 2026, reveal a market dominated by corporate actions, regulatory shifts, and capital structure changes, with several high-conviction signals for active investors. The most significant development is the forced delisting of Bowen Acquisition Corp (BOWN) from Nasdaq, a stark reminder of SPAC mortality risk. In the financial sector, Patriot National Bancorp's removal of its 'troubled condition' status marks a major turnaround, while XAI Octagon Floating Rate & Alternative Income Trust is embroiled in a proxy fight following severe underperformance. Capital markets are active, with Public Storage issuing $900M in debt to fund an acquisition and Research Alliance Corp IV launching a $75M SPAC IPO. On the earnings front, Onar Holding Corp reported a 39% revenue surge but with deteriorating margins and a precarious cash position, while Royale Energy narrowed its net loss by 42% despite a 14% revenue decline. Insider activity is notable at SharkNinja, where a waiver was granted for a chairman's share sale, and at Lisata Therapeutics, where a tender offer is set to close. Overall, the filings point to a bifurcated market where disciplined capital allocation and regulatory clarity are rewarded, while companies with weak balance sheets or governance issues face increasing scrutiny.

11 high priority 39 medium 50 total filings
· daily

US Material Events SEC 8-K Filings — July 10, 2026

The July 10, 2026, digest reveals a market dominated by capital structure engineering and defensive maneuvers, with 50 filings showing a clear bias toward financial restructuring, M&A execution, and governance changes. A significant theme is the prevalence of going-concern risks and cash preservation strategies, highlighted by InnSuites Hospitality Trust's auditor change citing going concern, ZyVersa Therapeutics' cost-cutting measures including potential 'going dark,' and multiple companies (BSTR Holdings, Faraday Future) relying on dilutive financing to survive. Conversely, a few companies are executing growth strategies, such as DXP Enterprises expanding its credit facility by $40M after a period of strong sales growth (sales rising from $1.1B to $2.1B) and Nuveen Churchill Direct Lending upsizing its debt offering. M&A activity is mixed, with a high-value SPAC merger (RF Acquisition Corp III / HCC Healthcare at $500M pre-money) and a strategic pivot by Nu-Med Plus into gold mining, contrasted by the termination of exclusivity in the Coeptis/Skycore deal. Insider activity is limited but notable, with the CEO and CFO of iQSTEL receiving compensation increases and the executives of ZyVersa taking voluntary pay cuts, signaling divergent management confidence. The overall sentiment is cautious, with a heavy focus on liquidity management and structural changes to address stock price or operational challenges.

50 high priority 50 total filings
· daily

Global High-Priority Regulatory Events — July 10, 2026

The July 10, 2026, filing batch reveals a pronounced wave of negative corporate actions, with a cluster of delistings (7 filings) and insolvency updates (5 filings) dominating the high-priority event landscape. A significant trend is the surge in SPAC activity, including a major valuation reduction in a pending merger (Plum Acquisition Corp IV cutting its target valuation by 30% to $3.15B) and multiple SPACs extending deadlines or completing IPOs, signaling both opportunity and distress in the blank-check sector. The healthcare and life sciences sector is a focal point for M&A, with GSK's $124/share tender offer for Nuvalent clearing its HSR waiting period and a $500M pre-money SPAC merger for HCC Healthcare. Financial distress is evident across several small-cap companies, with 4 Nasdaq non-compliance/delisting notices and a major fraud declaration by IREDA against Gensol Engineering for ₹672.74 Crore. From a period-over-period perspective, Rotographics' target Teneron showed an 11.3% YoY revenue decline, while Brandywine's office disposition removed $4.7M in quarterly revenue, highlighting asset-level pressure in commercial real estate. Insider activity is limited in this batch, but capital allocation patterns show a mix of strategic M&A, debt financing for acquisitions, and balance sheet restructuring through share cancellations and stock splits.

48 high priority 48 total filings
· daily

US SEC Filings Daily Market Digest — July 10, 2026

Today's filings reveal a market bifurcated between aggressive capital deployment and significant corporate restructuring. The standout event is SK hynix's massive $26.5 billion U.S. IPO, signaling strong demand for AI-related semiconductor exposure. Concurrently, we see a wave of SPAC activity with several transactions (RF Acquisition Corp III, BSTR Holdings, Eureka Acquisition) progressing, though many are renegotiating terms, indicating a maturing SPAC market. Capital return programs are active, with News Corp and Mission Produce executing buybacks, while DXP Enterprises and EquipmentShare are expanding credit facilities and raising guidance, pointing to operational confidence. However, significant risk is present: Zoomcar's massive potential dilution from a proposed 2 billion share increase, Outlook Therapeutics' precarious Nasdaq compliance, and InnSuites' going concern warning highlight ongoing distress in smaller caps. The period-over-period data shows strong growth in semiconductor (ChipMOS +37% YoY) and industrial (DXP sales nearly doubled from 2021 to 2026) sectors, while Ares Management's preliminary estimate of a tripling in performance income underscores robust alternative asset management trends. Insider activity is limited, but the sheer volume of capital markets activity (IPOs, debt offerings, SPAC mergers) suggests a high conviction environment for dealmakers.

13 high priority 37 medium 50 total filings